SHIVA - a web application for drug resistance and tropism testing in HIV

BackgroundDrug resistance testing is mandatory in antiretroviral therapy in human immunodeficiency virus (HIV) infected patients for successful treatment. The emergence of resistances against antiretroviral agents remains the major obstacle in inhibition of viral replication and thus to control infection. Due to the high mutation rate the virus is able to adapt rapidly under drug pressure leading to the evolution of resistant variants and finally to therapy failure.ResultsWe developed a web service for drug resistance prediction of commonly used drugs in antiretroviral therapy, i.e., protease inhibitors (PIs), reverse transcriptase inhibitors (NRTIs and NNRTIs), and integrase inhibitors (INIs), but also for the novel drug class of maturation inhibitors. Furthermore, co-receptor tropism (CCR5 or CXCR4) can be predicted as well, which is essential for treatment with entry inhibitors, such as Maraviroc. Currently, SHIVA provides 24 prediction models for several drug classes. SHIVA can be used with single RNA/DNA or amino acid sequences, but also with large amounts of next-generation sequencing data and allows prediction of a user specified selection of drugs simultaneously. Prediction results are provided as clinical reports which are sent via email to the user.ConclusionsSHIVA represents a novel high performing alternative for hitherto developed drug resistance testing approaches able to process data derived from next-generation sequencing technologies. SHIVA is publicly available via a user-friendly web interface.

[1]  Dominik Heider,et al.  A simple structure-based model for the prediction of HIV-1 co-receptor tropism , 2014, BioData Mining.

[2]  Dominik Heider,et al.  Prediction of Co-Receptor Usage of HIV-1 from Genotype , 2010, PLoS Comput. Biol..

[3]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[4]  Daniel Hoffmann,et al.  Machine learning on normalized protein sequences , 2011, BMC Research Notes.

[5]  Dominik Heider,et al.  gCUP: rapid GPU-based HIV-1 co-receptor usage prediction for next-generation sequencing , 2014, Bioinform..

[6]  Dominik Heider,et al.  Predicting Bevirimat resistance of HIV-1 from genotype , 2010, BMC Bioinformatics.

[7]  Huldrych F Günthard,et al.  2015 Update of the Drug Resistance Mutations in HIV-1. , 2015, Topics in antiviral medicine.

[8]  Thomas Lengauer,et al.  Bioinformatics prediction of HIV coreceptor usage , 2007, Nature Biotechnology.

[9]  David E. Martin,et al.  Maturation inhibitors: a new therapeutic class targets the virus structure. , 2007, AIDS reviews.

[10]  Jan Baumbach,et al.  Analysis of quality raw data of second generation sequencers with Quality Assessment Software , 2011, BMC Research Notes.

[11]  Andreas Prlic,et al.  Sequence analysis , 2003 .

[12]  Eyke Hüllermeier,et al.  Multilabel classification for exploiting cross-resistance information in HIV-1 drug resistance prediction , 2013, Bioinform..

[13]  Tommy F. Liu,et al.  Web resources for HIV type 1 genotypic-resistance test interpretation. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  David A. Price,et al.  Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity , 2005, Antimicrobial Agents and Chemotherapy.

[15]  Stephen C. Peiper,et al.  Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.

[16]  Dominik Heider,et al.  Interpol: An R package for preprocessing of protein sequences , 2011, BioData Mining.

[17]  R. Doolittle,et al.  A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.

[18]  Dominik Heider,et al.  Improved Bevirimat resistance prediction by combination of structural and sequence-based classifiers , 2011, BioData Mining.

[19]  D. Richman,et al.  2022 update of the drug resistance mutations in HIV-1. , 2022, Topics in antiviral medicine.

[20]  Thomas Lengauer,et al.  Diversity and complexity of HIV-1 drug resistance: A bioinformatics approach to predicting phenotype from genotype , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Margolick,et al.  Improved Coreceptor Usage Prediction and GenotypicMonitoring of R5-to-X4 Transition by Motif Analysis of HumanImmunodeficiency Virus Type 1 env V3 LoopSequences , 2003, Journal of Virology.

[22]  Dominik Heider,et al.  Structure of HIV-1 quasi-species as early indicator for switches of co-receptor tropism , 2010, AIDS research and therapy.